What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Osteoarthritis
Thomas J. Schnitzer mainly investigates Osteoarthritis, Internal medicine, Placebo, Surgery and Anesthesia.
His Osteoarthritis research is multidisciplinary, relying on both Gait, Physical therapy and Knee Joint.
The study incorporates disciplines such as Gastroenterology, Perforation and Ibuprofen in addition to Internal medicine.
His work in Gastroenterology tackles topics such as Upper gastrointestinal bleeding which are related to areas like Etoricoxib.
His Placebo research incorporates elements of Adverse effect, Clinical trial, Chemotherapy and WOMAC.
His research in Surgery intersects with topics in Urology, Rheumatoid arthritis, Osteoporosis, Naproxen and Bone remodeling.
His most cited work include:
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis (3548 citations)
- Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update (1557 citations)
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (1032 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Osteoarthritis, Internal medicine, Placebo, Physical therapy and Surgery.
Thomas J. Schnitzer interconnects Celecoxib, Visual analogue scale, Anesthesia and Adverse effect in the investigation of issues within Osteoarthritis.
His Internal medicine research includes themes of Gastroenterology, Endocrinology and Naproxen.
His Placebo research incorporates themes from Clinical trial, Tolerability, Randomized controlled trial, Chronic pain and WOMAC.
In his research, Back pain is intimately related to Neuroimaging, which falls under the overarching field of Chronic pain.
In his work, Osteoporosis, Bone remodeling and Femoral neck is strongly intertwined with Urology, which is a subfield of Surgery.
He most often published in these fields:
- Osteoarthritis (38.20%)
- Internal medicine (36.70%)
- Placebo (28.84%)
What were the highlights of his more recent work (between 2016-2021)?
- Osteoarthritis (38.20%)
- Placebo (28.84%)
- Internal medicine (36.70%)
In recent papers he was focusing on the following fields of study:
Thomas J. Schnitzer spends much of his time researching Osteoarthritis, Placebo, Internal medicine, Chronic pain and Tanezumab.
His Osteoarthritis research is multidisciplinary, incorporating elements of Nociception, Analgesic, Tolerability, Arthroplasty and Physical therapy.
His Analgesic research includes themes of Gastroenterology, Synovitis and Neutropenia.
The concepts of his Placebo study are interwoven with issues in Clinical trial, Adverse effect, Mixed anxiety-depressive disorder, Duloxetine and WOMAC.
His research investigates the connection between Chronic pain and topics such as Back pain that intersect with problems in Physical medicine and rehabilitation, Socioeconomic status, Clinical psychology and Naproxen.
His study in Tanezumab is interdisciplinary in nature, drawing from both Anesthesia, Joint pain, Randomization and Low back pain.
Between 2016 and 2021, his most popular works were:
- Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial (50 citations)
- A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis. (47 citations)
- Brain and psychological determinants of placebo pill response in chronic pain patients. (46 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Pathology
Thomas J. Schnitzer mostly deals with Placebo, Internal medicine, Osteoarthritis, Chronic pain and WOMAC.
His work carried out in the field of Placebo brings together such families of science as Clinical trial, Cortical bone, Bone resorption, Teriparatide and Bone remodeling.
His Internal medicine research incorporates elements of Orthopedic surgery and Distal femur.
He combines subjects such as Analgesic and Tolerability with his study of Osteoarthritis.
His work deals with themes such as Biomarker, Back pain and Functional magnetic resonance imaging, which intersect with Chronic pain.
His research investigates the connection with WOMAC and areas like Randomized controlled trial which intersect with concerns in Dentistry, Bone density and Bone adaptation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
